Filing Details
CRYO CELL INTERNATIONAL INC (NASDAQ:CCEL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 15, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CCEL
CRYO CELL INTERNATIONAL INC (CCEL) Files Quarterly Report for Q0
Filing Details CRYO CELL INTERNATIONAL INC (NASDAQ:CCEL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 15, 2026. The Healthcare…
Market Context
CRYO CELL INTERNATIONAL INC's stock currently trades at $3.58 with a market capitalization of $32.2M.
The 10-Q provides CRYO CELL INTERNATIONAL INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for CRYO CELL INTERNATIONAL INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CCEL Stock Page
Frequently Asked Questions
Where can I read CCEL's SEC filings?
Browse all filings on our CCEL SEC filings page.
What types of SEC filings does CRYO CELL INTERNATIONAL INC file?
Public companies like CRYO CELL INTERNATIONAL INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.